01/04/2015 - 13:24 SAN FRANCISCO – Weekly treatment with 40 mg of adalimumab yielded the strongest clinical responses in adults with moderate to severe hidradenitis su... More » Visit websiteField of Interest: DermatologyCategories: SAN || Conference NewsIMN || DermatologyIMN || NewsSAN || Clinical NewsSAN || NewsSAN || Acne & RosaceaAmerican Academy of DermatologyNews Feed: Internal Medicine News - Dermatology